文献速递脑血管病外科神经重症

家族性海绵状血管畸形综合征与脑淀粉样血管病的临床与影像学区别

Clinical and radiologic distinctions between familial cavernous malformation syndrome and cerebral amyloid angiopathy.
PubMed 文献 · Acta Neurochir (Wien) · 2024-12-23

本研究比较了确诊和疑似家族性脑海绵状血管畸形综合征(FCCM)患者与确诊和很可能脑淀粉样血管病(CAA)患者的临床与影像学特征,发现CAA患者年龄更大、认知主诉更多、家族史更少,而FCCM患者Zabramski 2型病灶、皮质下白质出血灶及基底节/内囊/小脑病灶更常见,出血灶皮质下白质与皮质带分布比≥1.0对FCCM有预测价值,作者提出FCCM标准。

要点

  • CAA患者年龄78.6岁 vs FCCM 43.4岁,认知主诉66.0% vs 8.3%,家族史4.0% vs 50.9%。
  • FCCM患者Zabramski 2型病灶0% CAA vs 79.6% FCCM,皮质下白质出血灶23.0% vs 99.1%。
  • 出血灶皮质下白质与皮质带分布比≥1.0预测FCCM:6.0% CAA vs 83.9% FCCM。

核心结论

  • 通过准确应用Boston 2.0标准、评估出血灶分布和类型以及评估FCCM特有的临床特征,可将FCCM患者与CAA可靠区分。
  • 作者提出FCCM标准。
  • FCCM患者中常见半卵圆中心白质疏松和血管周围间隙扩大,值得进一步研究。

研究设计与样本

  • 比较确诊FCCM(N=32)和疑似FCCM(n=76)患者与确诊CAA(N=29)和很可能CAA(N=21)患者的临床与影像学特征。

主要发现

  • CAA患者年龄78.6岁 vs FCCM 43.4岁(p < 0.0001)。
  • CAA患者认知主诉66.0% vs FCCM 8.3%(p < 0.0001)。
  • CAA患者家族史4.0% vs FCCM 50.9%(p < 0.0001)。
  • FCCM患者至少1个Zabramski 2型病灶0 CAA vs 79.6% FCCM(p < 0.0001)。
  • 任何皮质下白质出血灶23.0% CAA vs 99.1% FCCM(p < 0.0001);基底节、内囊或小脑病灶28.0% CAA vs 79.6% FCCM(p < 0.0001);皮质下白质与皮质带分布比≥1.0预测FCCM:6.0% CAA vs 83.9% FCCM(p < 0.0001)。

关键数值与推荐

  • CAA患者更常见白质病变、脑沟蛛网膜下腔出血和半卵圆中心血管周围间隙严重扩大,但这些特征均非CAA独有。
  • 符合Boston 2.0标准诊断CAA的FCCM患者(n=14)具有额外因素帮助与CAA区分。
  • 作者提出FCCM标准。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Familial cerebral cavernous malformation syndrome (FCCM) is characterized by multiple hemorrhagic lesions and is sometimes mistaken for cerebral amyloid angiopathy (CAA). METHODS: We compared clinical and radiologic characteristics in patients with definite (N = 32) and presumed FCCM (n = 76) to patients with definite (N = 29) and probable CAA (N = 21). RESULTS: Patients with CAA were older (78.6 years CAA vs. 43.4 FCCM; p < 0.0001), had cognitive complaints (66.0% CAA vs. 8.3% FCCM; p < 0.0001), and less likely to have a family history (4.0% CAA vs. 50.9% FCCM; p < 0.0001). FCCM patients were more likely to have at least 1 Zabramski type 2 lesion (0 CAA vs. 79.6% FCCM; p < 0.0001). Presence of any subcortical white matter hemorrhagic lesion (23.0% CAA vs. 99.1% FCCM; p < 0.0001), a lesion in either the basal ganglia, internal capsule or cerebellum (28.0% CAA vs 79.6% FCCM; p < 0.0001) and a subcortical white matter to cortical ribbon distribution of hemorrhagic lesions ≥ 1.0 was predictive of FCCM (6.0% CAA vs 83.9% FCCM; p < 0.0001). CAA patients more commonly had white matter disease, sulcal subarachnoid hemorrhage, and severely enlarged perivascular spaces in the centrum. However, none of the latter features were unique to CAA. FCCM patients meeting Boston 2.0 criteria for CAA (n = 14) had additional factors that helped distinguish them from CAA. CONCLUSIONS: Patients with FCCM can be reliably distinguished from CAA by accurately applying the Boston 2.0 criteria, assessing hemorrhagic lesion distribution and types, and assessing for clinical features unique to FCCM. FCCM criteria are proposed. The frequent finding of leukoaraiosis and enlarged perivascular spaces in the centrum semiovale in FCCM patients deserves further investigation.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Flemming KD, Radford JG, Reichard R, et al. Clinical and radiologic distinctions between familial cavernous malformation syndrome and cerebral amyloid angiopathy. Acta Neurochir (Wien). 2024. PMID: 39715886. doi:10.1007/s00701-024-06400-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。